PHASE-I TRIAL AND PHARMACOKINETICS OF AZIRIDINYLBENZOQUINONE (NSC-182986) IN HUMANS

被引:0
|
作者
SCHILSKY, RL
KELLEY, JA
IHDE, DC
HOWSER, DM
CORDES, RS
YOUNG, RC
机构
[1] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
[2] NCI,MED BRANCH,BETHESDA,MD 20205
[3] NCI,DIV CANC TREATMENT,MED CHEM & BIOL LAB,BETHESDA,MD 20205
[4] NCI,VET ADM,MED ONCOL BRANCH,BETHESDA,MD 20205
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1582 / 1586
页数:5
相关论文
共 50 条
  • [1] A PHASE-I TRIAL OF AZIRIDINYLBENZOQUINONE (NSC-182986) IN PATIENTS WITH PREVIOUSLY TREATED ACUTE-LEUKEMIA
    VANECHO, DA
    SCHULMAN, P
    BUDMAN, DR
    FERRARI, A
    WIERNIK, PH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (04): : 405 - 410
  • [2] PHASE-I STUDY OF AZIRIDINYLBENZOQUINONE (NSC 182986)
    BEDIKIAN, AY
    BODEY, GP
    BURGESS, MA
    FREIREICH, EJ
    CANCER CLINICAL TRIALS, 1981, 4 (04) : 459 - 463
  • [3] PHASE-I TRIAL OF CARBAMIC ACID (AZQ, NSC-182986)
    TAYLOR, SA
    BELT, RJ
    HAAS, CD
    HOOGSTRATEN, B
    STEPHENS, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 389 - 389
  • [4] PHARMACOKINETICS OF INTRAVENOUS (IV) AZIRIDINYLBENZOQUINONE (NSC-182986) IN CHILDREN
    HANCOCK, C
    YOUNG, C
    LEYLANDJONES, B
    KINAHAN, J
    CURRIE, V
    MILLER, L
    TAN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 136 - 136
  • [5] PHASE-I EVALUATION OF AZIRDINYLBENZOQUINONE (NSC-182986) IN A WEEKLY IV SCHEDULE
    BAKER, L
    SAMSON, M
    LEICHMAN, C
    YOUNG, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 189 - 189
  • [6] POTENTIAL ACTIVITY OF AZQ (AZIRIDINYLBENZOQUINONE, NSC-182986) IN RECURRENT GLIOMAS OF THE BRAIN
    DECKER, D
    ALSARRAF, M
    JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (03) : 290 - 290
  • [7] POTENTIAL ACTIVITY OF AZQ (AZIRIDINYLBENZOQUINONE, NSC-182986) IN RECURRENT GLIOMAS OF THE BRAIN
    PAZDUR, R
    DECKER, D
    ALSARRAF, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 178 - 178
  • [8] PRELIMINARY COMMUNICATION - TREATMENT OF PRIMARY BRAIN-TUMORS RECURRENT AFTER IRRADIATION WITH AZIRIDINYLBENZOQUINONE (AZQ - NSC-182986)
    EAGAN, RT
    DINAPOLI, RP
    HERMANN, RC
    GROOVER, RV
    LAYTON, DD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (05): : 577 - 578
  • [9] THE MURINE DISPOSITION AND PHARMACOKINETICS OF THE ANTI-NEOPLASTIC AGENT, DIAZIQUONE (NSC-182986)
    SPIEGEL, JF
    EGORIN, MJ
    COLLINS, JM
    LERNER, BD
    BACHUR, NR
    DRUG METABOLISM AND DISPOSITION, 1983, 11 (01) : 41 - 46
  • [10] PHASE-I STUDY OF AZIRIDINYLBENZOQUINONE (AZQ, NSC-183986) IN CHILDREN WITH CANCER
    TAN, C
    HANCOCK, C
    MILLER, L
    CAPARROS, B
    LEYLANDJONES, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 120 - 120